Mystic, CT, United States of America

Michael P Burns


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Mystic, CT (US) (2002 - 2012)
  • Waunakee, WI (US) (2012)

Company Filing History:


Years Active: 2002-2012

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovative Mind: Michael P. Burns and His Contributions to Bioconversion

Introduction

Michael P. Burns, an inventive mind based in Mystic, Connecticut, is known for his substantial contributions to the field of biochemistry through his innovative patents. With a total of four patents to his name, Burns's work primarily focuses on the stereoselective bioconversion of aliphatic dinitriles, showcasing his expertise in transforming complex chemical compounds into valuable intermediates for medical applications.

Latest Patents

Burns's latest patents revolve around the regio- and stereoselective bioconversion of selected aliphatic dinitriles into corresponding cyanocarboxylic acids. Specifically, he has developed methods for converting 2-isobutyl-succinonitrile into (S)-3 cyano-5-methylhexanoic acid. This particular compound serves as a crucial intermediate in the synthesis of (S)-3(aminomethyl)-5-methylhexanoic acid, commonly known as pregabalin. Pregabalin holds significant importance in the medical field, being used for the treatment and prevention of various cerebral diseases, including seizure disorders, pain management, and psychotic disorders.

Career Highlights

Currently, Michael P. Burns is associated with Pfizer Corporation, wherein he leverages his extensive knowledge and expertise to contribute to groundbreaking developments in biochemistry. His innovative research has not only advanced the understanding of bioconversion processes but has also opened doors for new therapeutic options in medicine.

Collaborations

Throughout his career, Burns has collaborated with talented individuals such as John Wing Wong and Justin K. Weaver, forging a path of collective innovation. These collaborations have enriched the research environment and have fostered a culture of creativity and advancement within their respective projects.

Conclusion

Michael P. Burns exemplifies the spirit of innovation in the realm of biochemistry. His pioneering work on the stereoselective bioconversion of aliphatic dinitriles has significant implications for modern medicine, particularly in developing treatments for debilitating neurological conditions. The journey of creativity and scientific inquiry continues for Burns as he contributes to the ever-evolving landscape of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…